Your browser doesn't support javascript.
loading
Preoperative Brain Tumor Imaging: Models and Software for Segmentation and Standardized Reporting.
Bouget, David; Pedersen, André; Jakola, Asgeir S; Kavouridis, Vasileios; Emblem, Kyrre E; Eijgelaar, Roelant S; Kommers, Ivar; Ardon, Hilko; Barkhof, Frederik; Bello, Lorenzo; Berger, Mitchel S; Conti Nibali, Marco; Furtner, Julia; Hervey-Jumper, Shawn; Idema, Albert J S; Kiesel, Barbara; Kloet, Alfred; Mandonnet, Emmanuel; Müller, Domenique M J; Robe, Pierre A; Rossi, Marco; Sciortino, Tommaso; Van den Brink, Wimar A; Wagemakers, Michiel; Widhalm, Georg; Witte, Marnix G; Zwinderman, Aeilko H; De Witt Hamer, Philip C; Solheim, Ole; Reinertsen, Ingerid.
Afiliación
  • Bouget D; Department of Health Research, SINTEF Digital, Trondheim, Norway.
  • Pedersen A; Department of Health Research, SINTEF Digital, Trondheim, Norway.
  • Jakola AS; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Kavouridis V; Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Emblem KE; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Eijgelaar RS; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Kommers I; Department of Neurosurgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Ardon H; Division of Radiology and Nuclear Medicine, Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway.
  • Barkhof F; Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
  • Bello L; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Berger MS; Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
  • Conti Nibali M; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Furtner J; Department of Neurosurgery, Twee Steden Hospital, Tilburg, Netherlands.
  • Hervey-Jumper S; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
  • Idema AJS; Institutes of Neurology and Healthcare Engineering, University College London, London, United Kingdom.
  • Kiesel B; Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università degli Studi di Milano, Milan, Italy.
  • Kloet A; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
  • Mandonnet E; Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università degli Studi di Milano, Milan, Italy.
  • Müller DMJ; Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Wien, Austria.
  • Robe PA; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
  • Rossi M; Department of Neurosurgery, Northwest Clinics, Alkmaar, Netherlands.
  • Sciortino T; Department of Neurosurgery, Medical University Vienna, Wien, Austria.
  • Van den Brink WA; Department of Neurosurgery, Haaglanden Medical Center, The Hague, Netherlands.
  • Wagemakers M; Department of Neurological Surgery, Hôpital Lariboisière, Paris, France.
  • Widhalm G; Department of Neurosurgery, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
  • Witte MG; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam University Medical Centers, Amsterdam, Netherlands.
  • Zwinderman AH; Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, Netherlands.
  • De Witt Hamer PC; Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università degli Studi di Milano, Milan, Italy.
  • Solheim O; Neurosurgical Oncology Unit, Department of Oncology and Hemato-Oncology, Humanitas Research Hospital, Università degli Studi di Milano, Milan, Italy.
  • Reinertsen I; Department of Neurosurgery, Isala, Zwolle, Netherlands.
Front Neurol ; 13: 932219, 2022.
Article en En | MEDLINE | ID: mdl-35968292
ABSTRACT
For patients suffering from brain tumor, prognosis estimation and treatment decisions are made by a multidisciplinary team based on a set of preoperative MR scans. Currently, the lack of standardized and automatic methods for tumor detection and generation of clinical reports, incorporating a wide range of tumor characteristics, represents a major hurdle. In this study, we investigate the most occurring brain tumor types glioblastomas, lower grade gliomas, meningiomas, and metastases, through four cohorts of up to 4,000 patients. Tumor segmentation models were trained using the AGU-Net architecture with different preprocessing steps and protocols. Segmentation performances were assessed in-depth using a wide-range of voxel and patient-wise metrics covering volume, distance, and probabilistic aspects. Finally, two software solutions have been developed, enabling an easy use of the trained models and standardized generation of clinical reports Raidionics and Raidionics-Slicer. Segmentation performances were quite homogeneous across the four different brain tumor types, with an average true positive Dice ranging between 80 and 90%, patient-wise recall between 88 and 98%, and patient-wise precision around 95%. In conjunction to Dice, the identified most relevant other metrics were the relative absolute volume difference, the variation of information, and the Hausdorff, Mahalanobis, and object average symmetric surface distances. With our Raidionics software, running on a desktop computer with CPU support, tumor segmentation can be performed in 16-54 s depending on the dimensions of the MRI volume. For the generation of a standardized clinical report, including the tumor segmentation and features computation, 5-15 min are necessary. All trained models have been made open-access together with the source code for both software solutions and validation metrics computation. In the future, a method to convert results from a set of metrics into a final single score would be highly desirable for easier ranking across trained models. In addition, an automatic classification of the brain tumor type would be necessary to replace manual user input. Finally, the inclusion of post-operative segmentation in both software solutions will be key for generating complete post-operative standardized clinical reports.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Neurol Año: 2022 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Neurol Año: 2022 Tipo del documento: Article País de afiliación: Noruega
...